Opioids, Formulary Management of Generics Focus of First Part D Proposed Regulation Since 2014

For the first time in three years, CMS has proposed a formal regulation concerning the Medicare Advantage (MA) and Medicare Part D prescription drug benefit programs. Typically, the agency has managed both benefits via the annual Call Letter process, which is subregulatory guidance. The proposed rule garnered a lot of speculation while it was under […]